Evidence map›Paper›PMID 31871933›Full record

ArticleBioMed research international2019

A Pharmacokinetic Interaction Study of Sorafenib and Iced Teas in Rats Using UPLC-MS/MS: An Illustration of Beverage-Drug Interaction.

Hadir M Maher, Aliyah Almomen, Nourah Z Alzoman, Shereen M Shehata, Amal Al-Subaie

Open access · hybridAbstract read
In one paragraph

Article in BioMed research international, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 81% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Hadir M MaherCollege of Pharmacy, Department of Pharmaceutical Chemistry, King Saud University, Riyadh 11495, P.O. Box 22452, Saudi Arabia.ORCID https://orcid.org/0000-0001-9891-9012
Aliyah AlmomenCollege of Pharmacy, Department of Pharmaceutical Chemistry, King Saud University, Riyadh 11495, P.O. Box 22452, Saudi Arabia.ORCID https://orcid.org/0000-0002-0181-6330
Nourah Z AlzomanCollege of Pharmacy, Department of Pharmaceutical Chemistry, King Saud University, Riyadh 11495, P.O. Box 22452, Saudi Arabia.ORCID https://orcid.org/0000-0003-4471-2344
Shereen M ShehataCollege of Pharmacy, Department of Pharmaceutical Chemistry, King Saud University, Riyadh 11495, P.O. Box 22452, Saudi Arabia.ORCID https://orcid.org/0000-0002-1441-2714
Amal Al-SubaieSaudi Food and Drug Authority, Biologics and Evaluation Department, Riyadh, Saudi Arabia.ORCID https://orcid.org/0000-0001-8757-694X
King Saud University · SASaudi Arabian Monetary Authority · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Iced teas (ITs), also known as ready-to-drink teas, have gained much popularity among many nations. The modulatory effect of tea beverages on CYP3A4 increases the possibility of their potential interactions with many coadministered medications. Being a substrate of CYP3A4, sorafenib (SOR), the first-line therapy for the treatment of hepatocellular carcinoma, shows a great probability to exhibit pharmacokinetic (PK) interaction with ITs. For this purpose, different groups of Wistar rats were given oral doses of SOR (40 mg/kg), along with different types of ITs. The concentration of SOR in rat plasma was determined using UPLC-MS/MS. Chromatographic analysis was performed on a C18 analytical column, Acquity UPLC BEH™ (100 × 1.0 mm, i.d., 1.7

Indexed as

AnimalsBeveragesCarcinoma, HepatocellularChromatography, LiquidCytochrome P-450 CYP3ADisease Models, AnimalDrug InteractionsErlotinib HydrochlorideLiver NeoplasmsMalePlant ExudatesRatsRats, WistarSorafenibTandem Mass SpectrometryTeaCytochrome P-450 CYP3AErlotinib HydrochloridePlant ExudatesSorafenibTea

Identifiers

PMID31871933
PMCPMC6907072
OpenAlexW2990167843

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.